Stockscreener 앱 받기
28.24
0.97%
0.27
시간 외 거래:
28.25
0.01
+0.04%
Moderna Inc 주식(MRNA)의 최신 뉴스
Moderna (MRNA) Under Scrutiny as FDA Investigates Vaccine Safety - GuruFocus
FDA expands COVID-19 shot safety probe to include adultsreport - Seeking Alpha
FDA Probes If Covid Shots Might Be Linked to Deaths of Adults - Bloomberg.com
Moderna to Host Investor Event – Analyst Day - Savannah Morning News
Moderna, Pfizer, and BioNTech stock briefly dips on FDA Covid vaccine probe - Investing.com Canada
MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy? - Finviz
Global AI Infrastructure Shift Ignites Biotech Growth Phase - Investing News Network
Dir Hussain Files To Sell 504 Of Moderna Inc [MRNA] - TradingView
Ossiam Has $3.08 Million Stake in Moderna, Inc. $MRNA - MarketBeat
CFO Mock Acquires 24,373 Of Moderna Inc [MRNA] - TradingView
Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Fut - GuruFocus
Moderna (MRNA) Just Reclaimed the 200-Day Moving Average - Yahoo Finance
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average - Nasdaq
Invesco Ltd. Has $195.92 Million Holdings in Moderna, Inc. $MRNA - MarketBeat
Lido Advisors LLC Sells 140,814 Shares of Moderna, Inc. $MRNA - MarketBeat
Federated Hermes Inc. Acquires 2,251,497 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories - Daily Commercial
How Recent Shifts Are Changing the Narrative for Moderna Stock - Yahoo Finance
58,854 Shares in Moderna, Inc. $MRNA Bought by Quantbot Technologies LP - MarketBeat
Moderna, Inc. $MRNA Stock Position Lessened by New York State Common Retirement Fund - MarketBeat
Behavioral Patterns of MRNA and Institutional Flows - news.stocktradersdaily.com
Moderna, Inc. (MRNA): A Bull Case Theory - MSN
Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates - Victorville Daily Press
Moderna (NASDAQ:MRNA) Shares Up 6.3%Still a Buy? - MarketBeat
Traders Purchase Large Volume of Moderna Call Options (NASDAQ:MRNA) - MarketBeat
Why Is Moderna (MRNA) Stock Rocketing Higher Today - Finviz
Synopsys, Moderna, Strategy, Q32 Bio, Wolfspeed: Stocks Making The Biggest Moves Today - MSN
Moderna (MRNA) Recently Broke Out Above the 20-Day Moving Average - Finviz
January 2026 Options Now Available For Moderna (MRNA) - Nasdaq
Skandinaviska Enskilda Banken AB publ Trims Position in Moderna, Inc. $MRNA - MarketBeat
Norges Bank Buys Shares of 3,439,999 Moderna, Inc. $MRNA - MarketBeat
Former FDA commissioners castigate plan to change vaccine approval standards - Seeking Alpha
Moderna to Present at Upcoming Investor Conferences in March 2024 - ACCESS Newswire
Moderna In Crisis? FDA Memo Ties Vaccines To Deaths, Stock Tumbles! - Smartkarma
Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock? - Finviz
Seasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035 - GlobeNewswire Inc.
CapEx per share of Moderna, Inc. – DUS:0QF - TradingView
The FDA’s Leaked Covid Memo Is Reckless and Dangerous - Bloomberg.com
Moderna, Inc. $MRNA Shares Sold by Hsbc Holdings PLC - MarketBeat
Goodwin Advises Moderna With Its $1.5 Billion Five-Year Credit Facility From Ares Management - Mondaq
Moderna (MRNA): Reassessing Valuation After FDA Signals Tougher Vaccine Approval Standards - Yahoo Finance
Officer Klinger Acquires 120 Of Moderna Inc [MRNA] - TradingView
Pres Hoge Acquires 336 Of Moderna Inc [MRNA] - TradingView
MVP: Williams & Connolly's David M. Krinsky - Law360
Transcript : Moderna, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 11 - MarketScreener
Moderna (MRNA) Responds to FDA Claims Regarding Vaccine Safety - GuruFocus
Moderna, Inc.: Financial Data Forecasts Estimates and Expectations | 0QF | US60770K1079 - marketscreener.com
Moderna, Inc.: Dividend historical data and projections - marketscreener.com
Prudential Financial Inc. Boosts Stake in Moderna, Inc. $MRNA - MarketBeat
Is Moderna Stock Underperforming the Nasdaq? - Barchart.com
Tougher FDA Rules on Vaccine Approval Might Change the Case for Investing in Moderna (MRNA) - Yahoo Finance
Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals - The Wall Street Journal
Moderna stock falls after FDA vows to impose new vaccine requirements - The Boston Globe
S&P 500 Gains and Losses Today: Moderna Falls; Synopsys Stock Climbs on Nvidia Partnership - Investopedia
Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 - Investor's Business Daily
Moderna, Other Pharma Stocks Close Lower After US FDA Reportedly Plans to Toughen Vaccine Approval - marketscreener.com
Moderna Falls As FDA Vows To Impose New Vaccine Rules - MarketScreener
FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
Moderna stock slides as FDA moves to tighten vaccine guidelines - Proactive financial news
Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More - Investopedia
Moderna (MRNA) Shares Drop Amid Stricter FDA Vaccine Approval St - GuruFocus
Stock Movers: Moderna, Synopsys, Barrick Mining - Bloomberg.com
Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals - Barron's
Moderna falls after FDA vows to impose new vaccine requirements - The Detroit News
Moderna, vaccine makers decline following FDA official comments on future approvals (MRNA:NASDAQ) - Seeking Alpha
Moderna Stock Drops as FDA Signals New Restrictions on Vaccine Approvals - Tokenist
1.50%
자본화:
|
볼륨(24시간):